# The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial

> **NCT05482698** · PHASE2 · COMPLETED · sponsor: **MC2 Therapeutics** · enrollment: 111 (actual)

## Conditions studied

- Chronic Kidney Disease-associated Pruritus

## Interventions

- **DRUG:** MC2-25 cream
- **DRUG:** MC2-25 vehicle

## Key facts

- **NCT ID:** NCT05482698
- **Lead sponsor:** MC2 Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2024-02-02
- **Final completion:** 2024-02-02
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05482698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05482698, "The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05482698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*